APT Medical Inc. (SHA:688617)
China · Delayed Price · Currency is CNY 258.57
-4.93 (-1.87%)
Aug 24, 2026, 3:00 PM CST
APT Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 932.79 | 820.64 | 673.15 | 533.92 | 358.02 | 207.92 |
Depreciation & Amortization | 117.37 | 109.75 | 87.44 | 64.84 | 48.26 | 33.44 |
Other Amortization | 3.98 | 3.07 | 3.6 | 3.06 | 3.22 | 1.11 |
Loss (Gain) From Sale of Assets | 1.26 | 0.93 | -0.25 | -10.81 | -0.06 | -0.02 |
Asset Writedown & Restructuring Costs | 1.39 | 1.86 | 0.83 | 3.97 | 10.68 | 3.57 |
Loss (Gain) From Sale of Investments | -29.04 | -17.42 | 3.53 | -23.13 | -21.09 | -32.82 |
Provision & Write-off of Bad Debts | 13.9 | 16.29 | 2.22 | -0.18 | 0.79 | -0.51 |
Other Operating Activities | 16.81 | 0.71 | 0.3 | 0.91 | -13.45 | -3.88 |
Change in Accounts Receivable | -133.03 | -120.86 | -74.73 | 20 | -23.17 | 4.3 |
Change in Inventory | -76.96 | -111.47 | -79.29 | 11.22 | -72.59 | -124.21 |
Change in Accounts Payable | 204.84 | 269.88 | 134.47 | 68.9 | 61.71 | 82.51 |
Change in Other Net Operating Assets | 23.44 | 5.69 | 7.24 | 21.28 | 14.19 | 18.17 |
Operating Cash Flow | 1,072 | 967.76 | 743.39 | 689.06 | 367.46 | 181.39 |
Operating Cash Flow Growth | 26.98% | 30.18% | 7.89% | 87.52% | 102.58% | 22.36% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -217.38 | -285.59 | -650.24 | -202.03 | -143.21 | -167.38 |
Sale of Property, Plant & Equipment | 0.79 | 0.22 | 0.6 | 12.67 | 0.23 | 0.04 |
Cash Acquisitions | - | - | - | -46.37 | - | - |
Investment in Securities | 67.86 | -223.07 | 23.84 | 797.82 | -39.16 | -947.7 |
Other Investing Activities | -9.49 | -10.75 | 8.01 | 19.82 | 47.61 | 4.93 |
Investing Cash Flow | -158.22 | -519.18 | -617.79 | 581.9 | -134.53 | -1,110 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 15 | 12.5 | - | - | - |
Long-Term Debt Issued | - | 4 | - | 70 | 82.6 | 23.5 |
Total Debt Issued | 20 | 19 | 12.5 | 70 | 82.6 | 23.5 |
Short-Term Debt Repaid | - | -0.37 | -5.04 | - | - | - |
Long-Term Debt Repaid | - | -11.02 | -82.74 | -49.62 | -84.16 | -35.72 |
Total Debt Repaid | -14.76 | -11.39 | -87.78 | -49.62 | -84.16 | -35.72 |
Net Debt Issued (Repaid) | 5.24 | 7.61 | -75.28 | 20.38 | -1.56 | -12.22 |
Issuance of Common Stock | 61.25 | 35.94 | 78.53 | 34.67 | - | 1,199 |
Repurchase of Common Stock | -549.98 | -99.94 | - | - | -59.99 | - |
Common Dividends Paid | -139.2 | -170.27 | -133.97 | -112.22 | -69.01 | -33.19 |
Other Financing Activities | -4.75 | -53.07 | -177.18 | -189.18 | -164.04 | -34.54 |
Financing Cash Flow | -627.44 | -279.74 | -307.9 | -246.36 | -294.6 | 1,119 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -21.81 | -3.79 | -13 | 2.84 | 0.96 | -1.02 |
Net Cash Flow | 264.93 | 165.04 | -195.3 | 1,027 | -60.71 | 189.32 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 855.01 | 682.17 | 93.15 | 487.03 | 224.25 | 14.01 |
Free Cash Flow Growth | 70.00% | 632.37% | -80.88% | 117.18% | 1500.56% | -86.53% |
Free Cash Flow Margin | 29.52% | 26.40% | 4.51% | 29.51% | 18.44% | 1.69% |
Free Cash Flow Per Share | 6.06 | 4.82 | 0.66 | 3.44 | 1.58 | 0.10 |
Levered Free Cash Flow | 579.46 | 365.94 | -330.9 | 353.19 | 263.62 | -35.72 |
Unlevered Free Cash Flow | 580.48 | 366.86 | -329.64 | 355.49 | 264.53 | -34.7 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 404.44 | 331.2 | 250.68 | 203.93 | 146.02 | 78.34 |
Change in Working Capital | 13.93 | 31.94 | -27.44 | 116.49 | -18.92 | -27.44 |